Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02218814 · ClinicalTrials.gov registry record · NA

Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA

A NA study of Arthroplasty, Replacement, Knee and Nerve Block, sponsored by George Macrinici.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT02218814 is a NA study of Arthroplasty, Replacement, Knee and Nerve Block that has completed, run by George Macrinici. The registered enrollment target is 106 participants, below the 194-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02218814, a NA study of Arthroplasty, Replacement, Knee and Nerve Block, has completed, sponsored by George Macrinici.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if patients undergoing a Total Knee Arthroplasty who receive a single shot Adductor Canal nerve block and local infiltration will have improved functional outcomes compared to individuals who receive a femoral nerve block and local infiltration during the first 24 hours post surgery.

Interventions

  • PROCEDURE Adductor Canal Block, Bupivacaine
  • PROCEDURE Femoral Nerve Block, Bupivacaine

Study Locations (1)

Illinois

  • Presence Saint Joseph Medical Center - Joliet

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2014-08
Est. Completion 2016-01
Phase NA

Sponsor

George Macrinici

1 total trials

What the Registry Record Tells You About NCT02218814

The ClinicalTrials.gov registry entry for NCT02218814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 194-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target (45% lower). The listed sponsor is George Macrinici, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Arthroplasty, Replacement, Knee appearing as the primary indexed condition, and to 2 interventions - of which Adductor Canal Block, Bupivacaine is the first listed.

NCT02218814 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02218814 about?

NCT02218814 is a clinical study titled "Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA". The purpose of this study is to determine if patients undergoing a Total Knee Arthroplasty who receive a single shot Adductor Canal nerve block and local infiltration will have improved functional outcomes compared to individuals who receive a femoral nerve block and local infiltration during the fi...

What is the current status of trial NCT02218814?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2014-08. Estimated completion is 2016-01.

What conditions does trial NCT02218814 study?

This clinical trial studies the following conditions: Arthroplasty, Replacement, Knee, Nerve Block.

What interventions are being tested in trial NCT02218814?

The interventions under investigation include: Adductor Canal Block, Bupivacaine (PROCEDURE), Femoral Nerve Block, Bupivacaine (PROCEDURE).

Who is sponsoring clinical trial NCT02218814?

This trial is sponsored by George Macrinici, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02218814 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty, Replacement, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.